News & Analysis as of

Cannabis Products Public Comment

Holland & Hart LLP

the buzz: Cannabis News & Policy Update - July 2024

Holland & Hart LLP on

Welcome to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry. - This month's highlights include: ...more

Bradley Arant Boult Cummings LLP

Now That It Appears Marijuana Is Being Rescheduled, How Does That Process Work?

As we at Budding Trends reported last week, the DEA is set to finally accept the recommendation of the U.S. Department of Health and Human Services (HHS) to reschedule marijuana from Schedule I to Schedule III under the...more

Bradley Arant Boult Cummings LLP

Texas Regulators to Consider Changes to Consumable Hemp Program

The Texas Health and Human Services Commission, on behalf of the Texas Department of State Health Services, recently announced that it was accepting public comments to the current rules governing consumer hemp products in the...more

Akin Gump Strauss Hauer & Feld LLP

Cannabis in 2024: HHS Rescheduling Recommendation and SAFER Banking

Key Points - The scientific review supporting HHS’s recommendation to DEA that cannabis be reclassified from a Schedule I to a Schedule III drug was published on January 12, 2024. Classifying cannabis as a Schedule III...more

Foley Hoag LLP - Cannabis and the Law

CCC Hosts Virtual Listening Session on Social Consumption Licensing

On July 18, 2023, the Cannabis Control Commission (“Commission”) hosted the second in a series of three public listening sessions on social consumption licenses. This session, the only one of the three sessions that will be...more

Saiber LLC

New Jersey CRC Approves Rules for Cannabis Consumption Lounges

Saiber LLC on

In a recent meeting, the New Jersey Cannabis Regulatory Commission approved proposed rules that will allow for the operation of cannabis consumption areas in New Jersey, more commonly referred to as cannabis lounges....more

Bradley Arant Boult Cummings LLP

Mississippi Department of Health Releases Proposed Modifications to Medical Cannabis Regulations

In the gift-giving spirit of the season, the Mississippi Department of Health has dropped proposed additions and revisions to the agency’s regulations for medical cannabis cultivators, processors, testing facilities,...more

Farella Braun + Martel LLP

California Cannabis Appellation Program

The specific location of a product’s origin is more important with some products than others. Wine is the classic example, as the dirt and surrounding climate in which grapes are grown can have a profound effect on the nature...more

The Rodman Law Group, LLC

New York Unveils Regulations for CBD Products

In late October, the New York State Department of Health (“DOH”) announced the release of the state’s long-awaited cannabidiol (“CBD”) guidelines. Reversing the state’s ban from last year on the sale of hemp-derived...more

The Rodman Law Group, LLC

Is the DEA Coming for the Hemp Industry After All?

On August 20, 2020, the United States Drug Enforcement Administration (“DEA”) issued an interim final rule (“IFR”) pertaining to the classifications of marijuana and hemp under the federal Controlled Substances Act (“CSA”) in...more

Foley Hoag LLP - Cannabis and the Law

CCC Sets The Table For Vote On Proposed Regulatory Changes

On August 28, 2020, the Cannabis Control Commission held a meeting to discuss the public comments on proposed amendments to the Commission’s adult-use and medical marijuana regulations. By way of background, the Commission...more

Womble Bond Dickinson

DEA Interim Final Rule on Hemp Draws Fire; Public Comment Period Ends 10/20/20

Womble Bond Dickinson on

The DEA published an interim final rule (IFR) late last week conforming its own regulations to meet Congress’ 2018 de-criminalization of hemp. The Agriculture Improvement Act of 2018 (the “2018 Farm Bill”) removed hemp from...more

International Cannabis Bar Association...

[Webinar] INCBA @ Berkeley Law: The Path to Appellations (Streaming Only Event) - April 2nd, 4:00 pm - 10:00 pm PT

We are excited to announce a groundbreaking program scheduled for April 2, 2020: The Path to Cannabis Appellations. The Cannabis Industry Club at the Hass School of Business and the Cannabis Law Society at the Berkeley...more

Farella Braun + Martel LLP

5 Key Highlights of the CDFA’s Proposed Cannabis Appellations Program

The California Department of Food & Agriculture (CDFA) recently released the first iteration of its Cannabis Appellations Program (CAP), which sets forth proposed regulations for licensed cultivators to establish appellations...more

McDermott Will & Emery

EPA Approves Use of 10 Pesticide Products on Hemp

McDermott Will & Emery on

December 19th, 2019, the Environmental Protection Agency (EPA) announced its approval of 10 new pesticides for use on hemp products. EPA’s approval of nine biopesticides and one conventional pesticide provides greater...more

Brownstein Hyatt Farber Schreck

FDA Cracks Down on Companies Selling CBD Products

The past year has seen a veritable tidal wave of consumer product marketing claiming that cannabidiol (CBD) infused or derived products cure or treat cancer, epilepsy, anxiety, inflammation, diabetes, Alzheimer’s disease,...more

Woods Rogers

Part 1: United States Department of Agriculture Publishes Interim Final Rule on Domestic Hemp Production

Woods Rogers on

Part I - On Thursday, October 31, 2019, the United States Department of Agriculture (USDA), Agriculture Marketing Service (AMS) published an interim final rule (Rule) on domestic hemp production in the Federal Register....more

Perkins Coie

USDA Issues Interim Rules Regarding Hemp Production (Finally)

Perkins Coie on

Since late February 2019, the U.S. Department of Agriculture (USDA) has been promising to publish guidelines regarding hemp production. Aside from the obvious importance of these guidelines to hemp farmers, the guidelines are...more

Foley & Lardner LLP

Key Takeaways from USDA’s Interim Hemp Production Rule

Foley & Lardner LLP on

On October 31, 2019 the U.S. Department of Agriculture (USDA) published an Interim Final Rule (84 FR 58522) establishing the U.S. Domestic Hemp Production Program and outlining a regulatory framework for monitoring hemp...more

King & Spalding

USDA Issues Interim Final Rule to Establish Domestic Hemp Production Program and Approve State and Tribal Oversight Plans

King & Spalding on

Effective upon Publication, USDA’s Interim Final Rule Sets Forth One Important Part of the Regime for Marketing Hemp Products in the United States - This week, the U.S. Department of Agriculture (USDA) issued an interim...more

Lowndes

Florida's Hemp Rules Released and Available for Public Comment Until Oct. 31

Lowndes on

On October 10, 2019, the Florida Department of Agriculture and Consumer Services (the “Department”) published the Notice of Proposed Rules for the State Hemp Program (the “Rules”). ...more

Shook, Hardy & Bacon L.L.P.

Food & Beverage Litigation Update l July 2019 #3

LEGISLATION, REGULATIONS & STANDARDS - AGs Submit Comment to FDA on Cannabis - A group of 38 state attorneys general have submitted a letter to the U.S. Food and Drug Administration (FDA) in response to the agency’s...more

Miller & Martin PLLC

FDA Extends Deadline to Submit Public Comment for Cannabis Products

Miller & Martin PLLC on

In its April 3, 2018 Federal Register Notice, the Food and Drug Administration (“FDA”)  announced its May 31, 2019 public hearing for the scientific data and information about products containing cannabis and cannabis derived...more

Wilson Sonsini Goodrich & Rosati

FDA Signals a Deliberative Approach to Cannabis at Public Hearing

While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a...more

McDermott Will & Emery

Learnings from the FDA Hearing on Cannabis and Cannabis-Derived Compounds

On Friday May 31, 2019, the Food and Drug Administration (FDA) held a public hearing on the topic of cannabis or cannabis-derived compounds. The FDA held the hearing to gather information regarding the safety risks and health...more

27 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide